StockData
Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc (BDRX) stock

BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.04−0.10 (-4.89%)

Close on Nov 18, 2026Market cap $4.60MP/E –Yield –

Biodexa Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -£5.59M. The highest annual figure on record is -£5.59M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-£5.59M–
FY2024Dec 31, 2024-£12.26M–
FY2023Dec 31, 2023-£6.83M–
FY2022Dec 31, 2022-£7.05M–
FY2021Dec 31, 2021-£6.01M–
FY2020Dec 31, 2020-£9.30M–
FY2019Dec 31, 2019-£6.49M–
FY2018Dec 31, 2018-£13.45M–
FY2017Dec 31, 2017-£12.95M–
FY2016Dec 31, 2016-£13.09M–
FY2015Dec 31, 2015-£12.42M–

More Biodexa Pharmaceuticals figures

See a number that looks wrong?